NCT01999166

Brief Summary

This study will investigate the genes responsible for osteoarthritis. Individuals with osteoarthritis known or suspected to be caused by a gene mutation (change) may be eligible for this study. Family members may also participate. Patients will talk with investigators who will explain the study and its possible implications for the patient and family and answer questions. The patient's medical records will be reviewed, a personal and family history will be taken, and a physical examination will be done. Two procedures may be done including blood sampling (which will be used for DNA (genetic) studies) and X-rays (to define osteoarthritis grade). If no known mutations responsible for osteoarthritis will be detected, participating family members will be interviewed by telephone about their personal and family health history and will have a blood sample drawn for DNA testing, and X-rays.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
5

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Oct 2014

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 14, 2013

Completed
19 days until next milestone

First Posted

Study publicly available on registry

December 3, 2013

Completed
10 months until next milestone

Study Start

First participant enrolled

October 7, 2014

Completed
7.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2021

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2022

Completed
Last Updated

July 30, 2025

Status Verified

July 1, 2025

Enrollment Period

7.2 years

First QC Date

November 14, 2013

Last Update Submit

July 25, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Identification of new gene mutations associated with early onset of osteoarthritis using NGS (Next Generation Sequencing)

    Clinical, genetic and imaging factors of osteoarthritis

    time of inclusion = Day 0

Study Arms (1)

Osteoarthritis

Radiation: radiography (X-ray)Genetic: DNA sampling

Interventions

Osteoarthritis
Osteoarthritis

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Family With Early Onset Osteoarthritis

You may qualify if:

  • Individuals (and family members) with early onset osteoarthritis according to the following definition:
  • symptomatic OA before 50 years old
  • no obvious causes of OA (IMC \> 30, dysplasia,joint traumas)
  • at least three OA locations

You may not qualify if:

  • Individuals younger than 18 years old.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU

Caen, France, 14000, France

Location

MeSH Terms

Conditions

Osteoarthritis

Interventions

X-Rays

Condition Hierarchy (Ancestors)

ArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Intervention Hierarchy (Ancestors)

Electromagnetic RadiationElectromagnetic PhenomenaMagnetic PhenomenaPhysical PhenomenaRadiationRadiation, Ionizing

Study Officials

  • Christian MARCELLI

    University Hospital, Caen

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
FAMILY BASED
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 14, 2013

First Posted

December 3, 2013

Study Start

October 7, 2014

Primary Completion

December 31, 2021

Study Completion

December 31, 2022

Last Updated

July 30, 2025

Record last verified: 2025-07

Locations